Hologic, Inc. · 2 weeks ago
Diagnostics Contracts Specialist 2
Hologic, Inc. is a company dedicated to improving women's health, and they are seeking a Diagnostics Contracts Specialist 2 to manage and negotiate various sales contracts. The role involves reviewing, drafting, and negotiating contracts, providing guidance on contract terms, and collaborating with internal teams to refine processes.
BiotechnologyHealth CareHealth DiagnosticsWomen's
Responsibilities
Review, draft, and negotiate contracts for commercial, government, and public health customers
Be the go-to expert for contract terms and offer guidance to colleagues and business partners
Research pricing and terms, and resolve those 'wait, what?' moments with finance and customer service
Build strong relationships with internal teams and help refine processes to keep us moving forward
Prepare proposals, agreements, and RFPs, and occasionally flex your cross-functional teamwork muscles
Qualification
Required
Bachelor's degree required
2–4 years of experience in a corporate, legal, or contracting department
Strong negotiation, analytical, and project management skills
Preferred
Paralegal certificate, MBA, or advanced degree is a plus
Experience with sales contracts in healthcare
Skilled in Microsoft Word, and willing to learn other Office apps
Salesforce and Ironclad experience are nice-to-haves
Company
Hologic, Inc.
We’re an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day.
H1B Sponsorship
Hologic, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (31)
2024 (20)
2023 (15)
2022 (32)
2021 (20)
2020 (14)
Funding
Current Stage
Public CompanyTotal Funding
$2.87B2025-10-21Private Equity
2025-10-21Acquired
2025-07-15Post Ipo Debt· $2.42B
Recent News
2026-01-17
Company data provided by crunchbase